Not counted: clinical trials of new HIV treatments are failing women
Lower chances of survival for people whose CD4 count remains under 500, Polish researchers report
Early action needed to prevent treatment failure, Nigerian research on detectable virus levels shows
Daily PrEP is safe for the kidneys, although on-demand PrEP has slightly less impact
Switching from TAF to older tenofovir may halt or reverse weight gain and lipid increases
The people who need injectable HIV drugs most are the ones who can’t get them, BHIVA told
People living with HIV still at higher risk of death by suicide, accident, violence, and substance use
Almost as many healthy years for people with undetectable HIV as HIV-negative people in South Africa
Second-line HIV treatment durable for eight years in Uganda
